An antimicrobial is an agent that kills microorganisms or stops their growth.[1] Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used against bacteria and antifungals are used against fungi.
How is Oxathiapiprolin synthesised?
Oxathiapiprolin is synthesised using 4- cyanopiperidine as a raw material by chemical reaction.
Feb 4，2024 Antimicrobial agent
Pyraziflumid: Synthesis and Introduction
Pyraziflumid is synthesised using ethyl 4,4,4-trifluoro-3-oxobutanoate as a raw material by chemical reaction.
Jan 31，2024 Antimicrobial agent
Isofetamid: Synthesis and Introduction
Isofetamid is synthesised using m-cresol as a raw material by chemical reaction. Isofetamid has been shown to be highly effective against Botrytis cinerea (grey mold) on grape.
Jan 31，2024 Antimicrobial agent
Evaluation of the efficacy safety and toxicity of Amphotericin B
Amphotericin B (AmB) is the oldest and for decades the only available agent for the treatment of life-threatening invasive fungal diseases, known for its broad-spectrum fungicidal activity against a w
Jan 22，2024 Antimicrobial agent
Rifampicin: Mechanism of action and Rifampicin resistance
Rifampicin is an important clinical antibiotic that belongs to the antimicrobial class of drugs. This drug is used for the management and treatment of various mycobacterial infections and gram-positiv
Jan 10，2024 Antimicrobial agent
How is Molnupiravir synthesised?
Molnupiravir is synthesised using uridine as a raw material by chemical reaction.
Jan 9，2024 Antimicrobial agent
Synthesis and Introduction of Fexinidazole
Fexinidazole is synthesised using nitroimidazole as a raw material by chemical reaction.
Jan 9，2024 Antimicrobial agent
Methylparaben：a preservative product
Methylparaben is a synthetic compound used as a preservative in cosmetics, skincare, and pharmaceutical products.
Dec 11，2023 Antimicrobial agentBretazenil (Ro 16-6028)
Bretazenil (Ro 16-6028) is a partial agonist at the GABAA benzodiazepine site. It displayed anticonvulsive activity and was in phase III of a clinical trial in Switzerland to treat Anxiety disorders.
Apr 20，2022 Antimicrobial agentEfavirenz---A first-line agent for HIV-1 infection
Efavirenz, earlier known as L-743,726 and DMP-266, is a benzoxazinone compound that was developed by DuPont Merck at Merck Research Laboratories and subsequently co-marketed by DuPont Merck Pharmaceut
Apr 19，2022 Antimicrobial agent